Search - tctmd.com

Displaying 701 - 720 of 924

Sort: Relevancy | Date

News Daily News

La FA es Habitual tras una Intervención de Sustitución de la Válvula Aórtica

Jason Kahn

January 30, 2014

News Daily News

A-fib Common After Aortic Valve Replacement

Jason Kahn

January 30, 2014

Presentation

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Presenter: T. Tanawuttiwat

January 29, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Jason Kahn

January 01, 2014

News Daily News

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

December 02, 2013

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

November 03, 2013

News Industry News

BOSTON SCIENTIFIC LOTUS™ VALVE SYSTEM MEETS

October 31, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

News Industry News

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Boston Scientific Receives CE Mark For Lotus™ Valve System

October 28, 2013

Advertisement

La FA es Habitual tras una Intervención de Sustitución de la Válvula Aórtica

A-fib Common After Aortic Valve Replacement

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Medtronic CoreValve® System Obtains Early FDA Approval

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

TAVR a Viable Option for Intermediate-Risk Patients

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

BOSTON SCIENTIFIC LOTUS™ VALVE SYSTEM MEETS

Two Trials to Assess TAVR in Moderate-Risk Patients

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

Opportunities Exist to Improve Outcomes in Transapical TAVR

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Boston Scientific Receives CE Mark For Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content